MarketCap
Facebook
X
Telegram
BioNano Genomics Market Cap | BNGO
As of October 06, 2026 BioNano Genomics has a market cap of $ 7.9 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap BioNano Genomics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.95 M | 3.55 M | 683 K | 37 M | 614 M | 1.47 B | 37.4 M | 40.8 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.47 B | 683 K | 276 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Diagnostics research industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Pacific Biosciences of California
PACB
|
498 M | $ 2.87 | 12.99 % | $ 861 M |  USA |
 |
Koninklijke Philips N.V.
PHG
|
30.3 B | $ 23.91 | 0.04 % | $ 22.7 B |  Niderland |
 |
Precipio
PRPO
|
38.4 M | $ 24.0 | 3.76 % | $ 38.5 M | USA |
 |
Personalis
PSNL
|
431 M | $ 16.4 | 0.74 % | $ 1.46 B | USA |
 |
Quidel Corporation
QDEL
|
10.6 B | $ 12.14 | 12.72 % | $ 511 M | USA |
 |
QIAGEN N.V.
QGEN
|
8.52 B | $ 45.79 | 2.34 % | $ 9.95 B | Niderland |
 |
RadNet
RDNT
|
5.62 B | $ 70.63 | 1.0 % | $ 5.31 B | USA |
 |
Senseonics Holdings
SENS
|
351 M | $ 10.31 | 4.35 % | $ 430 M | USA |
 |
Sotera Health Company
SHC
|
4.75 B | $ 18.55 | 1.81 % | $ 5.27 B | USA |
 |
Neuronetics
STIM
|
81.1 M | $ 2.2 | 1.85 % | $ 145 M | USA |
 |
Thermo Fisher Scientific
TMO
|
196 B | $ 676.76 | 3.35 % | $ 255 B | USA |
 |
Twist Bioscience Corporation
TWST
|
1.56 B | $ 205.0 | 8.66 % | $ 12.3 B | USA |
 |
VolitionRx Limited
VNRX
|
25.2 M | $ 0.23 | 0.35 % | $ 28.9 M |  Singapore |
 |
Waters Corporation
WAT
|
19.7 B | $ 440.12 | 3.51 % | $ 26.2 B | USA |
 |
Exagen
XGN
|
70.1 M | $ 8.46 | 3.55 % | $ 182 M | USA |
 |
Syneos Health
SYNH
|
9.41 B | - | - | $ 4.46 B | USA |
 |
Motus GI Holdings
MOTS
|
990 K | - | -34.28 % | $ 263 K |  Israel |
 |
Renalytix AI plc
RNLX
|
22.7 M | - | 5.66 % | $ 22.7 M |  Britain |
 |
Chembio Diagnostics
CEMI
|
12.6 M | - | 0.22 % | $ 16.8 M | USA |
 |
Psychemedics Corporation
PMD
|
16.8 M | - | -1.84 % | $ 15.3 M | USA |
 |
T2 Biosystems
TTOO
|
7.78 M | - | -39.35 % | $ 313 K | USA |
 |
DermTech
DMTK
|
42.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Meridian Bioscience
VIVO
|
1.38 B | - | - | $ 1.49 B | USA |
 |
Akumin
AKU
|
75.1 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
4.03 M | - | -61.36 % | $ 2.46 M | USA |
 |
Quotient Limited
QTNT
|
237 M | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Biocept
BIOC
|
5.93 M | - | -13.05 % | $ 7.29 M | USA |
 |
Invitae Corporation
NVTA
|
511 M | - | - | $ 21.2 M | USA |
 |
Brainsway Ltd.
BWAY
|
301 M | $ 12.23 | 1.35 % | $ 415 M | Israel |
 |
Trinity Biotech plc
TRIB
|
194 M | $ 5.77 | 1.41 % | $ 2.07 B |  Irlanda |
 |
Surmodics
SRDX
|
554 M | - | - | $ 608 M | USA |
 |
Heska Corporation
HSKA
|
844 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
2.99 M | - | -20.0 % | $ 1.06 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
421 M | - | - | $ 562 M | Britain |
 |
Fluidigm Corporation
FLDM
|
481 M | - | 1.08 % | $ 308 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
7.87 B | - | - | $ 10.7 B | USA |
|
Centogene N.V.
CNTG
|
10.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Global Cord Blood Corporation
CO
|
304 M | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
133 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
404 M | - | 0.12 % | $ 80.1 M | China |
 |
Aspira Women's Health
AWH
|
3.03 M | - | -6.19 % | $ 10.5 M | USA |
 |
Check-Cap Ltd.
CHEK
|
4.33 M | - | - | $ 9.42 M | Israel |
 |
Exact Sciences Corporation
EXAS
|
19.5 B | - | - | $ 19.8 B | USA |
 |
Interpace Biosciences
IDXG
|
7.34 M | $ 1.45 | 2.11 % | $ 6.41 M | USA |
 |
Organovo Holdings
ONVO
|
3.1 M | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
9.12 M | - | -16.95 % | $ 1.54 M | USA |
 |
PerkinElmer
PKI
|
14.1 B | - | -0.91 % | $ 14.7 B | USA |
 |
Soleno Therapeutics
SLNO
|
2.08 B | - | - | $ 2.69 B | USA |
 |
Enzo Biochem
ENZ
|
57.5 K | - | -8.98 % | $ 14.8 K | USA |
 |
Agilent Technologies
A
|
31.5 B | $ 171.29 | 2.09 % | $ 48.6 B | USA |